Palisade Bio (PALI) Short-Term Debt repayments (2013 - 2026)
Palisade Bio (PALI) reported Short-Term Debt repayments of $71000.0 for Q1 2026, down 11.25% year-over-year from $80000.0 in Q1 2025, and down 49.29% on a QoQ basis from $140000.0 in Q4 2025.
Palisade Bio (PALI) has 13 years of Short-Term Debt repayments data on file, last reported at $71000.0 in Q1 2026.
- Quarterly Short-Term Debt repayments fell 11.25% year-over-year to $71000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $311000.0 (down 10.63% YoY) and the FY2025 annual result came in at $320000.0, down 24.88% from the prior year.
- Short-Term Debt repayments eased to $71000.0 in Q1 2026 per PALI's latest filing, from $140000.0 in the prior quarter.
- Across five years, Short-Term Debt repayments topped out at $266000.0 in Q4 2022 and bottomed at $50000.0 in Q2 2023.
- The 5-year median for Short-Term Debt repayments is $112000.0 (2024), against an average of $133200.0.
- The widest annual swing landed in 2022, when Short-Term Debt repayments soared 690.91%; it then tumbled 71.1% in 2023.
- Tracing PALI's Short-Term Debt repayments over 5 years: stood at $266000.0 in 2022, then slumped by 62.03% to $101000.0 in 2023, then soared by 54.46% to $156000.0 in 2024, then fell by 10.26% to $140000.0 in 2025, then tumbled by 49.29% to $71000.0 in 2026.
- Per Business Quant, the three latest PALI Short-Term Debt repayments figures stand at $71000.0 (Q1 2026), $140000.0 (Q4 2025), and $100000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 102,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | 71,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71,000.00 |
| Mar 31, 2026 | 71,000.00 |
| Dec 31, 2025 | 140,000.00 |
| Dec 31, 2025 | 140,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 80,000.00 |
| Mar 31, 2025 | 80,000.00 |
| Dec 31, 2024 | 156,000.00 |
| Dec 31, 2024 | 156,000.00 |
| Sep 30, 2024 | 112,000.00 |
| Sep 30, 2024 | 112,000.00 |
| Mar 31, 2024 | 158,000.00 |
| Mar 31, 2024 | 158,000.00 |
| Dec 31, 2023 | 101,000.00 |
| Dec 31, 2023 | 101,000.00 |
| Sep 30, 2023 | 152,000.00 |
| Sep 30, 2023 | 152,000.00 |
| Jun 30, 2023 | 50,000.00 |
| Jun 30, 2023 | 50,000.00 |
| Mar 31, 2023 | 88,000.00 |
| Mar 31, 2023 | 88,000.00 |
| Dec 31, 2022 | 266,000.00 |
| Dec 31, 2022 | 266,000.00 |
| Sep 30, 2022 | 264,000.00 |
| Sep 30, 2022 | 264,000.00 |
| Jun 30, 2022 | 173,000.00 |
| Jun 30, 2022 | 173,000.00 |
| Mar 31, 2022 | 87,000.00 |
| Mar 31, 2022 | 87,000.00 |
| Dec 31, 2021 | 484,000.00 |
| Dec 31, 2021 | 484,000.00 |
| Sep 30, 2021 | 664,000.00 |
| Sep 30, 2021 | 664,000.00 |
| Jun 30, 2021 | 274,000.00 |
| Jun 30, 2021 | 274,000.00 |
| Mar 31, 2021 | 11,000.00 |
| Mar 31, 2021 | 11,000.00 |
| Dec 31, 2020 | 27,000.00 |
| Dec 31, 2020 | 27,000.00 |
| Jun 30, 2020 | -138,735.00 |
| Jun 30, 2020 | -138,735.00 |
| Mar 31, 2020 | 138,735.00 |
| Mar 31, 2020 | 138,735.00 |
| Dec 31, 2019 | 136,832.00 |
| Dec 31, 2019 | 136,832.00 |
| Sep 30, 2019 | 45,192.00 |
| Sep 30, 2019 | 45,192.00 |
| Jun 30, 2019 | 78,850.00 |
| Jun 30, 2019 | 78,850.00 |
| Mar 31, 2019 | 117,019.00 |
| Mar 31, 2019 | 117,019.00 |
| Dec 31, 2018 | 115,528.00 |
| Dec 31, 2018 | 115,528.00 |
| Sep 30, 2018 | 38,181.00 |
| Sep 30, 2018 | 38,181.00 |
| Jun 30, 2018 | 105,392.00 |
| Jun 30, 2018 | 105,392.00 |
| Mar 31, 2018 | 104,244.00 |
| Mar 31, 2018 | 104,244.00 |
| Dec 31, 2017 | 103,108.00 |
| Dec 31, 2017 | 103,108.00 |
| Sep 30, 2017 | 34,119.00 |
| Sep 30, 2017 | 34,119.00 |
| Jun 30, 2017 | 95,113.00 |
| Jun 30, 2017 | 95,113.00 |
| Mar 31, 2017 | 94,193.00 |
| Mar 31, 2017 | 94,193.00 |
| Jun 30, 2015 | 46,827.00 |
| Jun 30, 2015 | 46,827.00 |
| Mar 31, 2015 | 70,241.00 |
| Mar 31, 2015 | 70,241.00 |
| Dec 31, 2014 | 70,240.00 |
| Dec 31, 2014 | 70,240.00 |
| Sep 30, 2014 | 23,414.00 |
| Sep 30, 2014 | 23,414.00 |
| Jun 30, 2014 | 40,771.00 |
| Jun 30, 2014 | 40,771.00 |
| Mar 31, 2014 | 40,772.00 |
| Mar 31, 2014 | 40,772.00 |
| Dec 31, 2013 | 101,929.00 |
| Dec 31, 2013 | 101,929.00 |
| Jun 30, 2013 | 32,545.00 |
| Jun 30, 2013 | 32,545.00 |
| Mar 31, 2013 | 48,817.00 |
| Mar 31, 2013 | 48,817.00 |